Domperidone and ventricular arrhythmia or sudden cardiac death: A population-based case-control study in the Netherlands

Drug Safety

Volumn 33, Issue 11, 2010, Pages 1003-1014

  Van Noord, Charlotte ^a   Dieleman, Jeanne P ^a   Van Herpen, Gerard ^a   Verhamme, Katia ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Domperidone, adverse reactions; Dopamine D2 receptor antagonists, adverse reactions; QT interval prolongation, drug induced; Sudden death, drug induced; Ventricular arrhythmias, drug induced

Indexed keywords

DOMPERIDONE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE; SIDE EFFECT; SUDDEN DEATH; UNCONSCIOUSNESS;

ANTIEMETICS; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; DOMPERIDONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HEART VENTRICLES; HUMANS; LONGITUDINAL STUDIES; ODDS RATIO; POPULATION; RESEARCH DESIGN; RISK FACTORS; TIME FACTORS; TORSADES DE POINTES; VENTRICULAR FIBRILLATION;

EID: 77957763739     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11536840-000000000-00000     Document Type: Article

References (17)

1. Committee for Proprietary Medicinal Products (CPMP). Summary information on referral opinion following arbitration pursuant to article 30 of council directive 2001/83/EC for motilium and associated names. London: The European Agency for the Evaluation of Medicinal Products, 2002 Oct 17 [online]. Available from URL: EMEA/CPMP/4786/02/en/Final [Accessed 2009 Nov 1].
2. Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 2005 Oct; 26 (19): 2007-12
3. Drolet B, Rousseau G, Daleau P, et al. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000 Oct 17; 102 (16): 1883-5
4. Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002 May 1; 287 (17): 2215-20
5. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004 Mar 4; 350 (10): 1013-22
6. Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA 2003 Apr 23-30; 289 (16): 2120-7
7. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003 Nov; 89 (11): 1363-72
8. Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006 Jan 17; 47 (2): 362-7
9. Redfern WS, Carlsson L, Davis AS, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 2003; 58: 32-45
10. Medicines Control Council. Interaction between ketoconazole and domperidone and the risk of QT prolongation: important safety information. S Afr Med J 2006 Jul; 96 (7): 596
11. van der Lei J, Duisterhout JS, Westerhof HP, et al. The in-troduction of computer-based patient records in the Netherlands. Ann Intern Med 1993 Nov 15; 119 (10): 1036-41
12. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999 Dec; 38 (4-5): 339-44
13. Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fifteen years of evolution. Fam Pract 1992 Sep; 9 (3): 330-9
14. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001 Aug; 22 (16): 1374-450.
15. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens 1999 Feb; 17 (2): 151-83
16. Woosley RL. Drugs that prolong the QTc interval and/or induce Torsade de Pointes [online]. Available from URL: http:www.azcert.org/medical-pros/drug- lists/drug-lists.cfm [Accessed 2010 Aug 5]
17. Chugh SS, Jui J, Gunson K, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004 Sep 15; 44 (6): 1268-75